These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Clofazimine induced enteropathy--a case highlighting the importance of drug induced disease in differential diagnosis. Mathew BS; Pulimood AB; Prasanna CG; Ramakrishna BS; Chandy SJ Trop Gastroenterol; 2006; 27(2):87-8. PubMed ID: 17089619 [TBL] [Abstract][Full Text] [Related]
45. Study of toxicity of clofazimine with special reference to structural and functional status of small intestine. Kumar B; Bahadur B; Broor SL; Kaur S; Gangwar DN; Malik AK Lepr India; 1982 Apr; 54(2):246-55. PubMed ID: 7132294 [No Abstract] [Full Text] [Related]
47. [An unusual cause of parietal intestinal involvement: enteropathy due to clofazimine. Apropos of a case]. Hassan M; Chaumet S; Brauner M; Labadie H Ann Radiol (Paris); 1986; 29(6):549-52. PubMed ID: 3800268 [No Abstract] [Full Text] [Related]
48. Multi-drug therapy in bacilliferous leprosy--two years experience. Kaur S; Sharma VK; Kumar B; Singh M; Kaur I Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085 [TBL] [Abstract][Full Text] [Related]
49. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy. Reyes-Javier PD; Tantiongco PR Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801 [No Abstract] [Full Text] [Related]
50. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR; Shrestha K; Pandey B; Walker SL Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989 [TBL] [Abstract][Full Text] [Related]
51. Clofazimine induced nail changes. Dixit VB; Chaudhary SD; Jain VK Indian J Lepr; 1989 Oct; 61(4):476-8. PubMed ID: 2621382 [TBL] [Abstract][Full Text] [Related]
52. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally. Lockwood DN; Cunha Mda G Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024 [No Abstract] [Full Text] [Related]
53. Efficacy of topical 10% urea-based lotion in patients with ichthyosis vulgaris: a two-center, randomized, controlled, single-blind, right-vs.-left study in comparison with standard glycerol-based emollient cream. Tadini G; Giustini S; Milani M Curr Med Res Opin; 2011 Dec; 27(12):2279-84. PubMed ID: 22007909 [TBL] [Abstract][Full Text] [Related]
54. Clofazimine induced pigmentation in leprosy patches. Chavhan SD; Jawade S Pan Afr Med J; 2022; 42():14. PubMed ID: 35812254 [No Abstract] [Full Text] [Related]
55. Long-term clinical toxicity studies with clofazimine (B663) in leprosy. Hastings RC; Jacobson RR; Trautman JR Int J Lepr Other Mycobact Dis; 1976; 44(3):287-93. PubMed ID: 824210 [TBL] [Abstract][Full Text] [Related]
56. [Small intestine transit anomalies in a patient with chronic abdominal pain and treated for Hansen's disease]. Davy C; Riveau E; Bousquet JC; Curet P; Vayre P; Cortez A; Grellet J J Radiol; 1986 Mar; 67(3):213-8. PubMed ID: 3528476 [TBL] [Abstract][Full Text] [Related]
57. Clofazimine in pregnancy complicated by leprosy. Farb H; West DP; Pedvis-Leftick A Obstet Gynecol; 1982 Jan; 59(1):122-3. PubMed ID: 7078842 [TBL] [Abstract][Full Text] [Related]
58. Experience with multidrug therapy in paucibacillary leprosy. Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797 [TBL] [Abstract][Full Text] [Related]
59. Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS. Balakrishnan ; Seshadri PS Lepr India; 1981 Jan; 53(1):17-22. PubMed ID: 7218762 [TBL] [Abstract][Full Text] [Related]
60. Experience with the combination of clofazimine (Lamprene) and long-term steroid therapy in the treatment of leprosy. Hogerzeil LM Lepr India; 1976 Oct; 48(4 Suppl):718-21. PubMed ID: 1026809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]